上咽頭癌治療薬の世界市場レポート2020

• 英文タイトル：Global Nasopharyngeal Cancer Drug Sales Market Report 2020

• レポートコード：20QY06-06629 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、上咽頭癌治療薬のグローバル市場について種類別（BGBA317、CBT501、アパチニブ、APG1387、ARGX110、ATA129、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・上咽頭癌治療薬市場の概要 ・世界の主要地域別上咽頭癌治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の上咽頭癌治療薬市場規模2015-2026：種類別（BGBA317、CBT501、アパチニブ、APG1387、ARGX110、ATA129、その他） ・世界の上咽頭癌治療薬市場規模2015-2026：用途別（病院、クリニック、その他） ・上咽頭癌治療薬の北米市場規模2015-2020 ・上咽頭癌治療薬のヨーロッパ市場規模2015-2020 ・上咽頭癌治療薬の中国市場規模2015-2020 ・上咽頭癌治療薬の日本市場規模2015-2020 ・上咽頭癌治療薬の東南アジア市場規模2015-2020 ・上咽頭癌治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Ambrx Inc、arGEN-X BV、Atara Biotherapeutics Inc、AVEO Pharmaceuticals Inc、BeiGene Ltd、BioDiem Ltd、Biomics Biotechnologies Co Ltd、Bristol-Myers Squibb Company、CBT Pharmaceuticals Inc、Celgene Corp、Cell Medica Ltd、F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc） ・上咽頭癌治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・上咽頭癌治療薬の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Nasopharyngeal Cancer Drug Market
The global Nasopharyngeal Cancer Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Nasopharyngeal Cancer Drug Scope and Market Size
The global Nasopharyngeal Cancer Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nasopharyngeal Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Nasopharyngeal Cancer Drug market is segmented into
BGBA-317
CBT-501
Apatinib
APG-1387
ARGX-110
ATA-129
Others

Segment by Application, the Nasopharyngeal Cancer Drug market is segmented into
Hospital
Clinic
Others
The Nasopharyngeal Cancer Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Nasopharyngeal Cancer Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nasopharyngeal Cancer Drug Market Share Analysis
Nasopharyngeal Cancer Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nasopharyngeal Cancer Drug business, the date to enter into the Nasopharyngeal Cancer Drug market, Nasopharyngeal Cancer Drug product introduction, recent developments, etc.
The major vendors covered:
Ambrx Inc
arGEN-X BV
Atara Biotherapeutics Inc
AVEO Pharmaceuticals Inc
BeiGene Ltd
BioDiem Ltd
Biomics Biotechnologies Co Ltd
Bristol-Myers Squibb Company
CBT Pharmaceuticals Inc
Celgene Corp
Cell Medica Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc

レポート目次

---

Table of Contents

1 Nasopharyngeal Cancer Drug Market Overview
1.1 Nasopharyngeal Cancer Drug Product Scope
1.2 Nasopharyngeal Cancer Drug Segment by Type
1.2.1 Global Nasopharyngeal Cancer Drug Sales by Type (2020-2026)
1.2.2 BGBA-317
1.2.3 CBT-501
1.2.4 Apatinib
1.2.5 APG-1387
1.2.6 ARGX-110
1.2.7 ATA-129
1.2.8 Others
1.3 Nasopharyngeal Cancer Drug Segment by Application
1.3.1 Global Nasopharyngeal Cancer Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Nasopharyngeal Cancer Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nasopharyngeal Cancer Drug Sales Growth Rate (2015-2026)
1.4.2 Global Nasopharyngeal Cancer Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Nasopharyngeal Cancer Drug Price Trends (2015-2026)

2 Nasopharyngeal Cancer Drug Estimate and Forecast by Region
2.1 Global Nasopharyngeal Cancer Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nasopharyngeal Cancer Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nasopharyngeal Cancer Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Nasopharyngeal Cancer Drug Revenue Market Share by Region (2015-2020)
2.3 Global Nasopharyngeal Cancer Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nasopharyngeal Cancer Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nasopharyngeal Cancer Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nasopharyngeal Cancer Drug Estimates and Projections (2015-2026)
2.4.2 Europe Nasopharyngeal Cancer Drug Estimates and Projections (2015-2026)
2.4.3 China Nasopharyngeal Cancer Drug Estimates and Projections (2015-2026)
2.4.4 Japan Nasopharyngeal Cancer Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nasopharyngeal Cancer Drug Estimates and Projections (2015-2026)
2.4.6 India Nasopharyngeal Cancer Drug Estimates and Projections (2015-2026)
3 Global Nasopharyngeal Cancer Drug Competition Landscape by Players
3.1 Global Top Nasopharyngeal Cancer Drug Players by Sales (2015-2020)
3.2 Global Top Nasopharyngeal Cancer Drug Players by Revenue (2015-2020)
3.3 Global Nasopharyngeal Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasopharyngeal Cancer Drug as of 2019)
3.4 Global Nasopharyngeal Cancer Drug Average Price by Company (2015-2020)
3.5 Manufacturers Nasopharyngeal Cancer Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nasopharyngeal Cancer Drug Players (Opinion Leaders)
4 Global Nasopharyngeal Cancer Drug Market Size by Type
4.1 Global Nasopharyngeal Cancer Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Nasopharyngeal Cancer Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Nasopharyngeal Cancer Drug Price by Type (2014-2020)
4.2 Global Nasopharyngeal Cancer Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nasopharyngeal Cancer Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Nasopharyngeal Cancer Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Nasopharyngeal Cancer Drug Price Forecast by Type (2021-2026)
5 Global Nasopharyngeal Cancer Drug Market Size by Application
5.1 Global Nasopharyngeal Cancer Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Nasopharyngeal Cancer Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Nasopharyngeal Cancer Drug Price by Application (2015-2020)
5.2 Global Nasopharyngeal Cancer Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nasopharyngeal Cancer Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Nasopharyngeal Cancer Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Nasopharyngeal Cancer Drug Price Forecast by Application (2021-2026)

3 North America Nasopharyngeal Cancer Drug Market Facts & Figures
3.2 North America Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
3.3 North America Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
3.4 North America Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)

4 Europe Nasopharyngeal Cancer Drug Market Facts & Figures
4.2 Europe Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
4.3 Europe Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
4.4 Europe Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)

5 China Nasopharyngeal Cancer Drug Market Facts & Figures
5.2 China Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
5.3 China Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
5.4 China Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)

6 Japan Nasopharyngeal Cancer Drug Market Facts & Figures
6.2 Japan Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
6.3 Japan Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
6.4 Japan Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Nasopharyngeal Cancer Drug Market Facts & Figures
7.2 Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)

8 India Nasopharyngeal Cancer Drug Market Facts & Figures
8.2 India Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
8.3 India Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
8.4 India Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Nasopharyngeal Cancer Drug Business
12.1 Ambrx Inc
12.1.1 Ambrx Inc Nasopharyngeal Cancer Drug Corporation Information
12.1.2 Ambrx Inc Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.1.3 Ambrx Inc Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ambrx Inc Nasopharyngeal Cancer Drug Products Offered
12.1.5 Ambrx Inc Recent Development
12.2 arGEN-X BV
12.2.1 arGEN-X BV Nasopharyngeal Cancer Drug Corporation Information
12.2.2 arGEN-X BV Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.2.3 arGEN-X BV Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 arGEN-X BV Nasopharyngeal Cancer Drug Products Offered
12.2.5 arGEN-X BV Recent Development
12.3 Atara Biotherapeutics Inc
12.3.1 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Corporation Information
12.3.2 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.3.3 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Products Offered
12.3.5 Atara Biotherapeutics Inc Recent Development
12.4 AVEO Pharmaceuticals Inc
12.4.1 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Corporation Information
12.4.2 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.4.3 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Products Offered
12.4.5 AVEO Pharmaceuticals Inc Recent Development
12.5 BeiGene Ltd
12.5.1 BeiGene Ltd Nasopharyngeal Cancer Drug Corporation Information
12.5.2 BeiGene Ltd Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.5.3 BeiGene Ltd Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BeiGene Ltd Nasopharyngeal Cancer Drug Products Offered
12.5.5 BeiGene Ltd Recent Development
12.6 BioDiem Ltd
12.6.1 BioDiem Ltd Nasopharyngeal Cancer Drug Corporation Information
12.6.2 BioDiem Ltd Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.6.3 BioDiem Ltd Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BioDiem Ltd Nasopharyngeal Cancer Drug Products Offered
12.6.5 BioDiem Ltd Recent Development
12.7 Biomics Biotechnologies Co Ltd
12.7.1 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Corporation Information
12.7.2 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.7.3 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Products Offered
12.7.5 Biomics Biotechnologies Co Ltd Recent Development
12.8 Bristol-Myers Squibb Company
12.8.1 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Corporation Information
12.8.2 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.8.3 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Products Offered
12.8.5 Bristol-Myers Squibb Company Recent Development
12.9 CBT Pharmaceuticals Inc
12.9.1 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Corporation Information
12.9.2 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.9.3 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Products Offered
12.9.5 CBT Pharmaceuticals Inc Recent Development
12.10 Celgene Corp
12.10.1 Celgene Corp Nasopharyngeal Cancer Drug Corporation Information
12.10.2 Celgene Corp Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.10.3 Celgene Corp Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Celgene Corp Nasopharyngeal Cancer Drug Products Offered
12.10.5 Celgene Corp Recent Development
12.11 Cell Medica Ltd
12.11.1 Cell Medica Ltd Nasopharyngeal Cancer Drug Corporation Information
12.11.2 Cell Medica Ltd Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.11.3 Cell Medica Ltd Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Cell Medica Ltd Nasopharyngeal Cancer Drug Products Offered
12.11.5 Cell Medica Ltd Recent Development
12.12 F. Hoffmann-La Roche Ltd
12.12.1 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Corporation Information
12.12.2 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.12.3 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Products Offered
12.12.5 F. Hoffmann-La Roche Ltd Recent Development
12.13 GlaxoSmithKline Plc
12.13.1 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Corporation Information
12.13.2 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Business Overview and Total Revenue
12.13.3 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Products Offered
12.13.5 GlaxoSmithKline Plc Recent Development

13 Nasopharyngeal Cancer Drug Manufacturing Cost Analysis
13.1 Nasopharyngeal Cancer Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nasopharyngeal Cancer Drug
13.4 Nasopharyngeal Cancer Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nasopharyngeal Cancer Drug Distributors List
14.3 Nasopharyngeal Cancer Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Nasopharyngeal Cancer Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Nasopharyngeal Cancer Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Nasopharyngeal Cancer Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Nasopharyngeal Cancer Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Nasopharyngeal Cancer Drug Sales Market Share by Region (2015-2020)
Table 6. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Nasopharyngeal Cancer Drug Revenue Share by Region (2015-2020)
Table 8. Global Nasopharyngeal Cancer Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Nasopharyngeal Cancer Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Nasopharyngeal Cancer Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Nasopharyngeal Cancer Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Nasopharyngeal Cancer Drug Sales Share by Company (2015-2020)
Table 14. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Nasopharyngeal Cancer Drug Revenue Share by Company (2015-2020)
Table 16. Global Nasopharyngeal Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasopharyngeal Cancer Drug as of 2019)
Table 17. Global Nasopharyngeal Cancer Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Nasopharyngeal Cancer Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Nasopharyngeal Cancer Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Nasopharyngeal Cancer Drug Players
Table 22. Global Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Nasopharyngeal Cancer Drug Sales Share by Type (2015-2020)
Table 24. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Nasopharyngeal Cancer Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Nasopharyngeal Cancer Drug Sales Share by Type (2021-2026)
Table 27. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Nasopharyngeal Cancer Drug Revenue Share by Type (2021-2026)
Table 29. Global Nasopharyngeal Cancer Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Nasopharyngeal Cancer Drug Sales Share by Application (2015-2020)
Table 32. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Nasopharyngeal Cancer Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Nasopharyngeal Cancer Drug Sales Share by Application (2021-2026)
Table 36. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Nasopharyngeal Cancer Drug Revenue Share by Application (2021-2026)
Table 38. Global Nasopharyngeal Cancer Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Nasopharyngeal Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
Table 41. United States Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 43. United States Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Nasopharyngeal Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 51. China Nasopharyngeal Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
Table 53. China Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 55. China Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Nasopharyngeal Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Nasopharyngeal Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)
Table 69. India Nasopharyngeal Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Nasopharyngeal Cancer Drug Sales Market Share by Company (2015-2020)
Table 71. India Nasopharyngeal Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Nasopharyngeal Cancer Drug Sales Market Share by Type (2015-2020)
Table 73. India Nasopharyngeal Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Nasopharyngeal Cancer Drug Sales Market Share by Application (2015-2020)
Table 75. Ambrx Inc Corporation Information
Table 76. Ambrx Inc Description and Business Overview
Table 77. Ambrx Inc Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Ambrx Inc Nasopharyngeal Cancer Drug Product
Table 79. Ambrx Inc Recent Development
Table 80. arGEN-X BV Corporation Information
Table 81. arGEN-X BV Description and Business Overview
Table 82. arGEN-X BV Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. arGEN-X BV Nasopharyngeal Cancer Drug Product
Table 84. arGEN-X BV Recent Development
Table 85. Atara Biotherapeutics Inc Corporation Information
Table 86. Atara Biotherapeutics Inc Description and Business Overview
Table 87. Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Product
Table 89. Atara Biotherapeutics Inc Recent Development
Table 90. AVEO Pharmaceuticals Inc Corporation Information
Table 91. AVEO Pharmaceuticals Inc Description and Business Overview
Table 92. AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Product
Table 94. AVEO Pharmaceuticals Inc Recent Development
Table 95. BeiGene Ltd Corporation Information
Table 96. BeiGene Ltd Description and Business Overview
Table 97. BeiGene Ltd Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. BeiGene Ltd Nasopharyngeal Cancer Drug Product
Table 99. BeiGene Ltd Recent Development
Table 100. BioDiem Ltd Corporation Information
Table 101. BioDiem Ltd Description and Business Overview
Table 102. BioDiem Ltd Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. BioDiem Ltd Nasopharyngeal Cancer Drug Product
Table 104. BioDiem Ltd Recent Development
Table 105. Biomics Biotechnologies Co Ltd Corporation Information
Table 106. Biomics Biotechnologies Co Ltd Description and Business Overview
Table 107. Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Product
Table 109. Biomics Biotechnologies Co Ltd Recent Development
Table 110. Bristol-Myers Squibb Company Corporation Information
Table 111. Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Bristol-Myers Squibb Company Description and Business Overview
Table 113. Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Product
Table 114. Bristol-Myers Squibb Company Recent Development
Table 115. CBT Pharmaceuticals Inc Corporation Information
Table 116. CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. CBT Pharmaceuticals Inc Description and Business Overview
Table 118. CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Product
Table 119. CBT Pharmaceuticals Inc Recent Development
Table 120. Celgene Corp Corporation Information
Table 121. Celgene Corp Description and Business Overview
Table 122. Celgene Corp Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Celgene Corp Nasopharyngeal Cancer Drug Product
Table 124. Celgene Corp Recent Development
Table 125. Cell Medica Ltd Corporation Information
Table 126. Cell Medica Ltd Description and Business Overview
Table 127. Cell Medica Ltd Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Cell Medica Ltd Nasopharyngeal Cancer Drug Product
Table 129. Cell Medica Ltd Recent Development
Table 130. F. Hoffmann-La Roche Ltd Corporation Information
Table 131. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 132. F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. F. Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Product
Table 134. F. Hoffmann-La Roche Ltd Recent Development
Table 135. GlaxoSmithKline Plc Corporation Information
Table 136. GlaxoSmithKline Plc Description and Business Overview
Table 137. GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Product
Table 139. GlaxoSmithKline Plc Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Nasopharyngeal Cancer Drug Distributors List
Table 143. Nasopharyngeal Cancer Drug Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasopharyngeal Cancer Drug Product Picture
Figure 2. Global Nasopharyngeal Cancer Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nasopharyngeal Cancer Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Nasopharyngeal Cancer Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Nasopharyngeal Cancer Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Nasopharyngeal Cancer Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Nasopharyngeal Cancer Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Nasopharyngeal Cancer Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Nasopharyngeal Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Nasopharyngeal Cancer Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Nasopharyngeal Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Nasopharyngeal Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Nasopharyngeal Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Nasopharyngeal Cancer Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Nasopharyngeal Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Nasopharyngeal Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Nasopharyngeal Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Nasopharyngeal Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Nasopharyngeal Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Nasopharyngeal Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Nasopharyngeal Cancer Drug Players Market Share by Revenue in Nasopharyngeal Cancer Drug 2015 & 2019
Figure 27. Nasopharyngeal Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Nasopharyngeal Cancer Drug Revenue Share by Type (2015-2020)
Figure 29. Global Nasopharyngeal Cancer Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Nasopharyngeal Cancer Drug Revenue Share by Application (2015-2020)
Figure 31. Global Nasopharyngeal Cancer Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 33. United States Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 34. Europe Nasopharyngeal Cancer Drug Sales Market Share by Company in 2019
Figure 35. Europe Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 36. Europe Nasopharyngeal Cancer Drug Sales Market Share by Application in 2019
Figure 37. China Nasopharyngeal Cancer Drug Sales Market Share by Company in 2019
Figure 38. China Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 39. China Nasopharyngeal Cancer Drug Sales Market Share by Application in 2019
Figure 40. Japan Nasopharyngeal Cancer Drug Sales Market Share by Company in 2019
Figure 41. Japan Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 42. Japan Nasopharyngeal Cancer Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Nasopharyngeal Cancer Drug Sales Market Share by Application in 2019
Figure 46. India Nasopharyngeal Cancer Drug Sales Market Share by Company in 2019
Figure 47. India Nasopharyngeal Cancer Drug Sales Market Share by Type in 2019
Figure 48. India Nasopharyngeal Cancer Drug Sales Market Share by Application in 2019
Figure 49. Ambrx Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. arGEN-X BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Atara Biotherapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AVEO Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BeiGene Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. BioDiem Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biomics Biotechnologies Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. CBT Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Celgene Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Cell Medica Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Nasopharyngeal Cancer Drug
Figure 64. Manufacturing Process Analysis of Nasopharyngeal Cancer Drug
Figure 65. Nasopharyngeal Cancer Drug Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---